Keene & Associates’s Synaptics SYNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,255
Closed -$253K 81
2024
Q3
$253K Sell
3,255
-30
-0.9% -$2.41K 0.19% 72
2024
Q2
$290K Buy
3,285
+485
+17% +$43.9K 0.24% 69
2024
Q1
$273K Buy
2,800
+215
+8% +$22.6K 0.2% 76
2023
Q4
$295K Sell
2,585
-125
-5% -$12.4K 0.24% 68
2023
Q3
$242K Buy
+2,710
New +$238K 0.19% 74
2023
Q2
Sell
-2,146
Closed -$239K 81
2023
Q1
$239K Hold
2,146
0.18% 74
2022
Q4
$204K Buy
+2,146
New +$206K 0.18% 71
2022
Q3
Sell
-1,916
Closed -$226K 81
2022
Q2
$226K Buy
1,916
+688
+56% +$101K 0.21% 74
2022
Q1
$245K Buy
1,228
+192
+19% +$42.6K 0.2% 76
2021
Q4
$300K Buy
+1,036
New +$247K 0.26% 65

Other funds holding SYNA

Keene & Associates's SYNA Position: Q4 2024 in Review

Keene & Associates sold out of Synaptics (SYNA) in Q4 2024, closing a stake of 3,255 shares — an estimated $253K sold.

Keene & Associates first reported a position in SYNA in Q4 2021 and held it in 10 quarters. The position peaked at $300K in Q4 2021. 263 funds tracked by Wall St. Rank hold SYNA as of Q4 2024.

  • Keene & Associates reported no remaining Synaptics position as of Q4 2024 after selling out during the quarter.
  • Keene & Associates sold 3,255 Synaptics shares in Q4 2024, an estimated $253K.
  • Keene & Associates first reported a position in Synaptics in Q4 2021 and held it in 10 quarters.
  • Keene & Associates's Synaptics position peaked at $300K in Q4 2021.
  • 263 funds tracked by Wall St. Rank held Synaptics as of Q4 2024.

Based on Keene & Associates's 13F filing for Q4 2024, filed 3 Feb 2025.